date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.409194055400758.
The log-likelihood improved by 2.769.
Iteration 2 of at most 500:
Optimizing with step length 0.578859683791977.
The log-likelihood improved by 3.968.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.3391.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.9784.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       4       20     1176      994      762      360      367      369 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     357      221      163       98       50       35       14        4 
degree16 degree17 degree18 
       4        1        1 
1 
disease_progression 
H-positive risk:  912 862 111 895 437 111 861 477 99 69 115 51 
H-negative risk:  862 912 861 895 477 437 111 111 115 99 51 69 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
47 new agents 
2 
disease_progression 
H-positive risk:  915 865 112 895 434 111 856 477 98 66 120 51 
H-negative risk:  865 915 856 895 477 434 111 112 120 98 51 66 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
60 new agents 
3 
disease_progression 
H-positive risk:  924 873 112 894 434 112 853 468 99 63 118 50 
H-negative risk:  873 924 853 894 468 434 112 112 118 99 50 63 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
4 
disease_progression 
H-positive risk:  925 874 117 891 428 115 851 468 100 63 118 50 
H-negative risk:  874 925 851 891 468 428 115 117 118 100 50 63 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 6 1 

clinical_engagement 
diagnosis 
demography 
60 new agents 
5 
disease_progression 
H-positive risk:  926 881 116 883 431 120 854 459 102 61 117 50 
H-negative risk:  881 926 854 883 459 431 120 116 117 102 50 61 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 7 2 

clinical_engagement 
diagnosis 
demography 
71 new agents 
6 
disease_progression 
H-positive risk:  929 888 118 886 434 119 853 448 100 60 116 49 
H-negative risk:  888 929 853 886 448 434 119 118 116 100 49 60 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 9 1 

clinical_engagement 
diagnosis 
demography 
59 new agents 
7 
disease_progression 
H-positive risk:  933 891 120 889 427 118 849 443 99 65 117 49 
H-negative risk:  891 933 849 889 443 427 118 120 117 99 49 65 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 11 2 

clinical_engagement 
diagnosis 
demography 
51 new agents 
8 
disease_progression 
H-positive risk:  937 892 122 886 424 120 848 442 101 64 115 49 
H-negative risk:  892 937 848 886 442 424 120 122 115 101 49 64 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 12 5 

clinical_engagement 
diagnosis 
demography 
54 new agents 
9 
disease_progression 
H-positive risk:  937 900 122 883 421 121 847 441 101 64 113 50 
H-negative risk:  900 937 847 883 441 421 121 122 113 101 50 64 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 13 5 

clinical_engagement 
diagnosis 
demography 
63 new agents 
10 
disease_progression 
H-positive risk:  941 913 122 877 417 122 837 442 101 64 112 52 
H-negative risk:  913 941 837 877 442 417 122 122 112 101 52 64 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 18 4 

clinical_engagement 
diagnosis 
demography 
53 new agents 
11 
disease_progression 
H-positive risk:  948 916 123 874 413 123 831 439 103 66 113 51 
H-negative risk:  916 948 831 874 439 413 123 123 113 103 51 66 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 20 9 

clinical_engagement 
diagnosis 
demography 
58 new agents 
12 
disease_progression 
H-positive risk:  951 921 124 865 410 126 831 435 102 65 117 53 
H-negative risk:  921 951 831 865 435 410 126 124 117 102 53 65 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 21 11 

clinical_engagement 
diagnosis 
demography 
52 new agents 
13 
disease_progression 
H-positive risk:  870 841 109 949 411 117 912 428 109 64 137 53 
H-negative risk:  841 870 912 949 428 411 117 109 137 109 53 64 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 21 13 

clinical_engagement 
diagnosis 
demography 
233 new agents 
14 
disease_progression 
H-positive risk:  899 876 114 895 451 121 870 420 98 72 130 54 
H-negative risk:  876 899 870 895 420 451 121 114 130 98 54 72 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 25 13 

clinical_engagement 
diagnosis 
demography 
69 new agents 
15 
disease_progression 
H-positive risk:  905 888 113 888 448 121 868 416 97 71 130 55 
H-negative risk:  888 905 868 888 416 448 121 113 130 97 55 71 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 28 14 

clinical_engagement 
diagnosis 
demography 
57 new agents 
16 
disease_progression 
H-positive risk:  911 889 116 893 442 121 866 417 95 71 126 53 
H-negative risk:  889 911 866 893 417 442 121 116 126 95 53 71 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 30 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
17 
disease_progression 
H-positive risk:  923 891 116 893 432 125 872 410 95 70 123 50 
H-negative risk:  891 923 872 893 410 432 125 116 123 95 50 70 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 30 13 

clinical_engagement 
diagnosis 
demography 
59 new agents 
18 
disease_progression 
H-positive risk:  934 888 121 894 423 122 876 405 94 69 123 51 
H-negative risk:  888 934 876 894 405 423 122 121 123 94 51 69 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 31 12 

clinical_engagement 
diagnosis 
demography 
55 new agents 
19 
disease_progression 
H-positive risk:  941 892 121 889 417 121 875 402 96 66 127 53 
H-negative risk:  892 941 875 889 402 417 121 121 127 96 53 66 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 31 12 

clinical_engagement 
diagnosis 
demography 
80 new agents 
20 
disease_progression 
H-positive risk:  952 896 120 887 415 121 871 396 98 65 125 54 
H-negative risk:  896 952 871 887 396 415 121 120 125 98 54 65 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 33 12 

clinical_engagement 
diagnosis 
demography 
50 new agents 
21 
disease_progression 
H-positive risk:  948 902 120 885 417 122 869 396 100 65 124 52 
H-negative risk:  902 948 869 885 396 417 122 120 124 100 52 65 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 33 12 

clinical_engagement 
diagnosis 
demography 
53 new agents 
22 
disease_progression 
H-positive risk:  951 906 121 883 412 120 869 393 103 66 125 51 
H-negative risk:  906 951 869 883 393 412 120 121 125 103 51 66 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 34 12 

clinical_engagement 
diagnosis 
demography 
57 new agents 
23 
disease_progression 
H-positive risk:  959 904 121 887 405 120 866 389 103 66 128 52 
H-negative risk:  904 959 866 887 389 405 120 121 128 103 52 66 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 34 12 

clinical_engagement 
diagnosis 
demography 
69 new agents 
24 
disease_progression 
H-positive risk:  956 912 119 889 398 120 872 386 103 66 127 52 
H-negative risk:  912 956 872 889 386 398 120 119 127 103 52 66 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 36 12 

clinical_engagement 
diagnosis 
demography 
63 new agents 
25 
disease_progression 
H-positive risk:  896 842 116 956 394 110 934 390 112 66 133 51 
H-negative risk:  842 896 934 956 390 394 110 116 133 112 51 66 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 35 12 

clinical_engagement 
diagnosis 
demography 
170 new agents 
26 
disease_progression 
H-positive risk:  911 867 117 917 417 111 903 395 112 68 127 55 
H-negative risk:  867 911 903 917 395 417 111 117 127 112 55 68 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 33 12 

clinical_engagement 
diagnosis 
demography 
78 new agents 
27 
disease_progression 
H-positive risk:  915 872 114 910 419 110 895 399 114 68 128 56 
H-negative risk:  872 915 895 910 399 419 110 114 128 114 56 68 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 33 12 

clinical_engagement 
diagnosis 
demography 
56 new agents 
28 
disease_progression 
H-positive risk:  915 877 112 899 419 111 901 398 115 69 127 57 
H-negative risk:  877 915 901 899 398 419 111 112 127 115 57 69 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 36 12 

clinical_engagement 
diagnosis 
demography 
47 new agents 
29 
disease_progression 
H-positive risk:  912 879 112 904 419 113 904 386 116 69 128 58 
H-negative risk:  879 912 904 904 386 419 113 112 128 116 58 69 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 40 13 

clinical_engagement 
diagnosis 
demography 
56 new agents 
30 
disease_progression 
H-positive risk:  917 884 111 903 416 115 899 386 118 65 127 59 
H-negative risk:  884 917 899 903 386 416 115 111 127 118 59 65 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 42 14 

clinical_engagement 
diagnosis 
demography 
59 new agents 
31 
disease_progression 
H-positive risk:  920 890 111 902 414 117 898 377 118 66 125 62 
H-negative risk:  890 920 898 902 377 414 117 111 125 118 62 66 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 42 15 

clinical_engagement 
diagnosis 
demography 
62 new agents 
32 
disease_progression 
H-positive risk:  926 897 114 900 414 119 894 371 116 65 123 61 
H-negative risk:  897 926 894 900 371 414 119 114 123 116 61 65 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 43 15 

clinical_engagement 
diagnosis 
demography 
58 new agents 
33 
disease_progression 
H-positive risk:  933 898 116 900 410 120 893 364 116 65 124 61 
H-negative risk:  898 933 893 900 364 410 120 116 124 116 61 65 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 45 14 

clinical_engagement 
diagnosis 
demography 
66 new agents 
34 
disease_progression 
H-positive risk:  940 893 117 898 406 123 893 365 116 65 126 58 
H-negative risk:  893 940 893 898 365 406 123 117 126 116 58 65 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 45 14 

clinical_engagement 
diagnosis 
demography 
74 new agents 
35 
disease_progression 
H-positive risk:  938 897 115 900 401 125 894 362 113 65 129 61 
H-negative risk:  897 938 894 900 362 401 125 115 129 113 61 65 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 46 14 

clinical_engagement 
diagnosis 
demography 
66 new agents 
36 
disease_progression 
H-positive risk:  944 908 114 898 396 124 891 355 114 66 130 60 
H-negative risk:  908 944 891 898 355 396 124 114 130 114 60 66 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 48 17 

clinical_engagement 
diagnosis 
demography 
55 new agents 
37 
disease_progression 
H-positive risk:  871 855 107 960 396 116 956 352 124 66 138 59 
H-negative risk:  855 871 956 960 352 396 116 107 138 124 59 66 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 49 17 

clinical_engagement 
diagnosis 
demography 
165 new agents 
38 
disease_progression 
H-positive risk:  884 871 111 925 412 115 926 377 123 62 140 54 
H-negative risk:  871 884 926 925 377 412 115 111 140 123 54 62 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 49 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
39 
disease_progression 
H-positive risk:  885 873 110 924 400 117 925 381 122 64 142 57 
H-negative risk:  873 885 925 924 381 400 117 110 142 122 57 64 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 50 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
40 
disease_progression 
H-positive risk:  887 883 108 923 396 114 924 377 123 65 144 56 
H-negative risk:  883 887 924 923 377 396 114 108 144 123 56 65 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 50 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
41 
disease_progression 
H-positive risk:  886 887 110 924 394 114 921 376 122 65 145 56 
H-negative risk:  887 886 921 924 376 394 114 110 145 122 56 65 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 53 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
42 
disease_progression 
H-positive risk:  887 894 110 929 386 117 923 369 119 67 143 56 
H-negative risk:  894 887 923 929 369 386 117 110 143 119 56 67 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 52 17 

clinical_engagement 
diagnosis 
demography 
80 new agents 
43 
disease_progression 
H-positive risk:  900 894 111 929 382 117 924 363 118 67 140 55 
H-negative risk:  894 900 924 929 363 382 117 111 140 118 55 67 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 51 17 

clinical_engagement 
diagnosis 
demography 
58 new agents 
44 
disease_progression 
H-positive risk:  898 896 111 933 376 119 928 360 116 68 141 54 
H-negative risk:  896 898 928 933 360 376 119 111 141 116 54 68 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 54 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
45 
disease_progression 
H-positive risk:  891 899 110 941 375 123 927 359 115 65 142 53 
H-negative risk:  899 891 927 941 359 375 123 110 142 115 53 65 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 54 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
46 
disease_progression 
H-positive risk:  899 900 110 946 373 125 917 359 115 65 140 51 
H-negative risk:  900 899 917 946 359 373 125 110 140 115 51 65 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 54 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
47 
disease_progression 
H-positive risk:  903 901 113 942 377 127 911 357 115 65 139 50 
H-negative risk:  901 903 911 942 357 377 127 113 139 115 50 65 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 56 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
48 
disease_progression 
H-positive risk:  907 899 115 954 375 129 905 345 117 64 140 50 
H-negative risk:  899 907 905 954 345 375 129 115 140 117 50 64 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 58 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
49 
disease_progression 
H-positive risk:  832 831 104 1021 383 126 979 339 119 63 152 51 
H-negative risk:  831 832 979 1021 339 383 126 104 152 119 51 63 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 59 17 

clinical_engagement 
diagnosis 
demography 
125 new agents 
50 
disease_progression 
H-positive risk:  840 833 109 996 401 127 962 351 117 59 150 55 
H-negative risk:  833 840 962 996 351 401 127 109 150 117 55 59 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 60 17 

clinical_engagement 
diagnosis 
demography 
90 new agents 
51 
disease_progression 
H-positive risk:  841 835 111 991 398 127 966 346 119 62 148 56 
H-negative risk:  835 841 966 991 346 398 127 111 148 119 56 62 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 64 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
52 
disease_progression 
H-positive risk:  845 836 110 993 397 128 975 338 120 59 145 54 
H-negative risk:  836 845 975 993 338 397 128 110 145 120 54 59 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 63 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
53 
disease_progression 
H-positive risk:  845 846 112 997 393 127 971 339 118 55 141 56 
H-negative risk:  846 845 971 997 339 393 127 112 141 118 56 55 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 60 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
54 
disease_progression 
H-positive risk:  850 845 115 993 386 126 967 343 118 58 141 58 
H-negative risk:  845 850 967 993 343 386 126 115 141 118 58 58 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 61 19 

clinical_engagement 
diagnosis 
demography 
54 new agents 
55 
disease_progression 
H-positive risk:  855 846 113 988 381 126 964 349 118 57 142 61 
H-negative risk:  846 855 964 988 349 381 126 113 142 118 61 57 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 63 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
56 
disease_progression 
H-positive risk:  862 854 115 992 376 125 956 348 118 55 140 59 
H-negative risk:  854 862 956 992 348 376 125 115 140 118 59 55 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 63 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
57 
disease_progression 
H-positive risk:  854 849 117 1000 380 124 958 349 118 52 140 59 
H-negative risk:  849 854 958 1000 349 380 124 117 140 118 59 52 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
58 
disease_progression 
H-positive risk:  856 852 119 1003 376 127 952 344 119 53 139 60 
H-negative risk:  852 856 952 1003 344 376 127 119 139 119 60 53 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
59 
disease_progression 
H-positive risk:  852 846 123 1008 373 126 957 347 116 55 139 58 
H-negative risk:  846 852 957 1008 347 373 126 123 139 116 58 55 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
60 
disease_progression 
H-positive risk:  850 844 121 1015 373 125 964 342 118 52 137 59 
H-negative risk:  844 850 964 1015 342 373 125 121 137 118 59 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
61 
disease_progression 
H-positive risk:  802 782 112 1073 374 117 1008 346 127 51 149 59 
H-negative risk:  782 802 1008 1073 346 374 117 112 149 127 59 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
133 new agents 
62 
disease_progression 
H-positive risk:  816 796 111 1061 377 119 983 356 121 52 147 61 
H-negative risk:  796 816 983 1061 356 377 119 111 147 121 61 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
63 
disease_progression 
H-positive risk:  830 803 114 1056 368 119 970 356 121 51 148 64 
H-negative risk:  803 830 970 1056 356 368 119 114 148 121 64 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
64 
disease_progression 
H-positive risk:  836 800 117 1058 362 118 965 359 120 54 148 63 
H-negative risk:  800 836 965 1058 359 362 118 117 148 120 63 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
65 
disease_progression 
H-positive risk:  842 805 118 1052 365 119 965 354 119 53 146 62 
H-negative risk:  805 842 965 1052 354 365 119 118 146 119 62 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
66 
disease_progression 
H-positive risk:  844 807 119 1042 372 122 965 353 120 51 144 61 
H-negative risk:  807 844 965 1042 353 372 122 119 144 120 61 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
67 
disease_progression 
H-positive risk:  855 807 121 1042 369 122 960 351 122 52 141 58 
H-negative risk:  807 855 960 1042 351 369 122 121 141 122 58 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
68 
disease_progression 
H-positive risk:  857 803 121 1046 369 121 961 346 125 51 142 58 
H-negative risk:  803 857 961 1046 346 369 121 121 142 125 58 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
69 
disease_progression 
H-positive risk:  861 798 121 1049 370 123 957 344 122 52 143 60 
H-negative risk:  798 861 957 1049 344 370 123 121 143 122 60 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
70 
disease_progression 
H-positive risk:  860 801 121 1052 366 124 958 336 126 52 143 61 
H-negative risk:  801 860 958 1052 336 366 124 121 143 126 61 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
71 
disease_progression 
H-positive risk:  858 810 122 1047 360 126 967 333 126 51 142 58 
H-negative risk:  810 858 967 1047 333 360 126 122 142 126 58 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
72 
disease_progression 
H-positive risk:  848 807 121 1052 361 129 968 331 129 51 145 58 
H-negative risk:  807 848 968 1052 331 361 129 121 145 129 58 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
73 
disease_progression 
H-positive risk:  796 761 116 1104 359 122 1026 323 137 46 151 59 
H-negative risk:  761 796 1026 1104 323 359 122 116 151 137 59 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
133 new agents 
74 
disease_progression 
H-positive risk:  812 768 115 1081 373 126 993 346 136 39 145 66 
H-negative risk:  768 812 993 1081 346 373 126 115 145 136 66 39 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
75 
disease_progression 
H-positive risk:  808 771 113 1078 382 124 994 346 135 40 144 65 
H-negative risk:  771 808 994 1078 346 382 124 113 144 135 65 40 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
76 
disease_progression 
H-positive risk:  801 765 112 1072 382 126 998 356 136 39 148 65 
H-negative risk:  765 801 998 1072 356 382 126 112 148 136 65 39 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
77 
disease_progression 
H-positive risk:  809 764 111 1076 380 127 991 353 136 41 145 67 
H-negative risk:  764 809 991 1076 353 380 127 111 145 136 67 41 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
78 
disease_progression 
H-positive risk:  809 772 107 1072 377 124 988 360 137 42 145 67 
H-negative risk:  772 809 988 1072 360 377 124 107 145 137 67 42 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
79 
disease_progression 
H-positive risk:  813 776 106 1059 381 123 984 366 135 46 147 64 
H-negative risk:  776 813 984 1059 366 381 123 106 147 135 64 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
80 
disease_progression 
H-positive risk:  813 782 106 1049 384 122 985 370 133 46 147 63 
H-negative risk:  782 813 985 1049 370 384 122 106 147 133 63 46 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
81 
disease_progression 
H-positive risk:  814 789 108 1041 386 124 985 365 133 46 148 61 
H-negative risk:  789 814 985 1041 365 386 124 108 148 133 61 46 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
82 
disease_progression 
H-positive risk:  812 797 108 1041 381 123 985 365 136 45 147 60 
H-negative risk:  797 812 985 1041 365 381 123 108 147 136 60 45 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
83 
disease_progression 
H-positive risk:  811 806 110 1036 380 125 984 366 134 45 146 57 
H-negative risk:  806 811 984 1036 366 380 125 110 146 134 57 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
84 
disease_progression 
H-positive risk:  816 797 113 1043 373 127 983 369 135 45 143 56 
H-negative risk:  797 816 983 1043 369 373 127 113 143 135 56 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
85 
disease_progression 
H-positive risk:  768 760 107 1090 368 122 1030 368 141 46 146 54 
H-negative risk:  760 768 1030 1090 368 368 122 107 146 141 54 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
100 new agents 
86 
disease_progression 
H-positive risk:  762 765 113 1081 373 121 1007 389 146 45 144 54 
H-negative risk:  765 762 1007 1081 389 373 121 113 144 146 54 45 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 96 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
87 
disease_progression 
H-positive risk:  755 764 114 1084 369 124 1020 383 149 43 144 51 
H-negative risk:  764 755 1020 1084 383 369 124 114 144 149 51 43 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 95 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
88 
disease_progression 
H-positive risk:  758 764 113 1083 367 121 1028 381 149 39 147 50 
H-negative risk:  764 758 1028 1083 381 367 121 113 147 149 50 39 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
89 
disease_progression 
H-positive risk:  762 761 112 1085 375 116 1019 382 154 38 146 50 
H-negative risk:  761 762 1019 1085 382 375 116 112 146 154 50 38 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
90 
disease_progression 
H-positive risk:  766 768 111 1090 364 115 1025 378 153 38 146 46 
H-negative risk:  768 766 1025 1090 378 364 115 111 146 153 46 38 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
91 
disease_progression 
H-positive risk:  762 769 111 1084 365 119 1031 380 147 39 146 47 
H-negative risk:  769 762 1031 1084 380 365 119 111 146 147 47 39 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
92 
disease_progression 
H-positive risk:  764 770 111 1074 366 124 1034 377 149 38 147 46 
H-negative risk:  770 764 1034 1074 377 366 124 111 147 149 46 38 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
93 
disease_progression 
H-positive risk:  774 767 110 1078 364 124 1023 382 147 37 147 47 
H-negative risk:  767 774 1023 1078 382 364 124 110 147 147 47 37 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
94 
disease_progression 
H-positive risk:  779 776 113 1071 366 124 1018 378 147 35 147 46 
H-negative risk:  776 779 1018 1071 378 366 124 113 147 147 46 35 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
59 new agents 
95 
disease_progression 
H-positive risk:  785 778 111 1059 367 122 1018 380 148 37 151 44 
H-negative risk:  778 785 1018 1059 380 367 122 111 151 148 44 37 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
96 
disease_progression 
H-positive risk:  792 781 111 1061 359 120 1012 384 149 35 152 44 
H-negative risk:  781 792 1012 1061 384 359 120 111 152 149 44 35 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
97 
disease_progression 
H-positive risk:  758 735 102 1108 354 110 1048 390 155 37 156 47 
H-negative risk:  735 758 1048 1108 390 354 110 102 156 155 47 37 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
97 new agents 
98 
disease_progression 
H-positive risk:  756 721 103 1109 365 111 1039 397 154 41 154 50 
H-negative risk:  721 756 1039 1109 397 365 111 103 154 154 50 41 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
99 
disease_progression 
H-positive risk:  759 722 103 1109 371 110 1035 393 151 42 155 50 
H-negative risk:  722 759 1035 1109 393 371 110 103 155 151 50 42 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
100 
disease_progression 
H-positive risk:  756 722 104 1116 364 112 1038 388 151 44 158 47 
H-negative risk:  722 756 1038 1116 388 364 112 104 158 151 47 44 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
101 
disease_progression 
H-positive risk:  757 725 107 1110 362 111 1046 376 153 46 162 45 
H-negative risk:  725 757 1046 1110 376 362 111 107 162 153 45 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
102 
disease_progression 
H-positive risk:  766 724 108 1112 364 111 1038 370 152 49 163 43 
H-negative risk:  724 766 1038 1112 370 364 111 108 163 152 43 49 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
103 
disease_progression 
H-positive risk:  766 730 106 1117 368 107 1042 354 151 49 166 44 
H-negative risk:  730 766 1042 1117 354 368 107 106 166 151 44 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
104 
disease_progression 
H-positive risk:  765 732 108 1108 368 104 1038 360 155 51 166 45 
H-negative risk:  732 765 1038 1108 360 368 104 108 166 155 45 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
105 
disease_progression 
H-positive risk:  766 733 107 1106 374 105 1034 360 153 52 165 45 
H-negative risk:  733 766 1034 1106 360 374 105 107 165 153 45 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
106 
disease_progression 
H-positive risk:  766 731 111 1103 374 104 1029 359 158 54 166 45 
H-negative risk:  731 766 1029 1103 359 374 104 111 166 158 45 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
107 
disease_progression 
H-positive risk:  771 727 111 1098 378 105 1022 361 160 55 166 46 
H-negative risk:  727 771 1022 1098 361 378 105 111 166 160 46 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
108 
disease_progression 
H-positive risk:  771 729 113 1096 382 107 1023 355 162 52 162 48 
H-negative risk:  729 771 1023 1096 355 382 107 113 162 162 48 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
109 
disease_progression 
H-positive risk:  738 693 103 1132 373 98 1056 359 169 55 174 50 
H-negative risk:  693 738 1056 1132 359 373 98 103 174 169 50 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
97 new agents 
110 
disease_progression 
H-positive risk:  735 700 103 1125 381 101 1035 372 168 58 170 52 
H-negative risk:  700 735 1035 1125 372 381 101 103 170 168 52 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
111 
disease_progression 
H-positive risk:  728 694 104 1127 377 101 1041 377 167 64 169 51 
H-negative risk:  694 728 1041 1127 377 377 101 104 169 167 51 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
112 
disease_progression 
H-positive risk:  727 692 102 1123 376 102 1041 381 169 64 172 51 
H-negative risk:  692 727 1041 1123 381 376 102 102 172 169 51 64 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
113 
disease_progression 
H-positive risk:  728 683 104 1127 376 97 1042 383 172 64 173 51 
H-negative risk:  683 728 1042 1127 383 376 97 104 173 172 51 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
114 
disease_progression 
H-positive risk:  733 691 100 1127 370 95 1040 380 173 62 174 55 
H-negative risk:  691 733 1040 1127 380 370 95 100 174 173 55 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
115 
disease_progression 
H-positive risk:  728 686 101 1129 374 96 1041 381 174 65 170 55 
H-negative risk:  686 728 1041 1129 381 374 96 101 170 174 55 65 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
116 
disease_progression 
H-positive risk:  724 686 100 1127 377 92 1051 378 179 61 168 57 
H-negative risk:  686 724 1051 1127 378 377 92 100 168 179 57 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
117 
disease_progression 
H-positive risk:  720 695 100 1126 367 89 1052 377 183 62 170 59 
H-negative risk:  695 720 1052 1126 377 367 89 100 170 183 59 62 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
118 
disease_progression 
H-positive risk:  720 691 99 1127 373 89 1049 378 183 63 171 57 
H-negative risk:  691 720 1049 1127 378 373 89 99 171 183 57 63 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
119 
disease_progression 
H-positive risk:  722 695 98 1121 373 91 1050 374 183 62 173 58 
H-negative risk:  695 722 1050 1121 374 373 91 98 173 183 58 62 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
120 
disease_progression 
H-positive risk:  720 703 101 1120 373 92 1056 365 179 60 174 57 
H-negative risk:  703 720 1056 1120 365 373 92 101 174 179 57 60 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 99 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
121 
disease_progression 
H-positive risk:  681 661 95 1166 369 87 1095 366 183 59 180 58 
H-negative risk:  661 681 1095 1166 366 369 87 95 180 183 58 59 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 101 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
122 
disease_progression 
H-positive risk:  678 662 93 1156 380 90 1089 377 180 58 177 60 
H-negative risk:  662 678 1089 1156 377 380 90 93 177 180 60 58 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 101 22 

clinical_engagement 
diagnosis 
demography 
90 new agents 
123 
disease_progression 
H-positive risk:  686 663 94 1151 378 90 1094 373 179 58 176 58 
H-negative risk:  663 686 1094 1151 373 378 90 94 176 179 58 58 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 102 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
124 
disease_progression 
H-positive risk:  689 667 94 1154 375 91 1088 370 179 58 177 58 
H-negative risk:  667 689 1088 1154 370 375 91 94 177 179 58 58 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 103 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
125 
disease_progression 
H-positive risk:  690 666 94 1157 378 88 1090 364 181 58 173 61 
H-negative risk:  666 690 1090 1157 364 378 88 94 173 181 61 58 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 104 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
126 
disease_progression 
H-positive risk:  694 678 95 1154 376 82 1085 366 181 56 171 62 
H-negative risk:  678 694 1085 1154 366 376 82 95 171 181 62 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 101 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
127 
disease_progression 
H-positive risk:  694 679 98 1152 368 82 1085 371 182 56 170 63 
H-negative risk:  679 694 1085 1152 371 368 82 98 170 182 63 56 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 103 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
128 
disease_progression 
H-positive risk:  691 678 99 1144 368 84 1088 370 187 54 173 64 
H-negative risk:  678 691 1088 1144 370 368 84 99 173 187 64 54 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 104 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
129 
disease_progression 
H-positive risk:  696 677 101 1144 374 85 1085 362 191 52 173 60 
H-negative risk:  677 696 1085 1144 362 374 85 101 173 191 60 52 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 100 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
130 
disease_progression 
H-positive risk:  693 677 102 1138 376 87 1095 358 187 50 176 61 
H-negative risk:  677 693 1095 1138 358 376 87 102 176 187 61 50 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 101 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
131 
disease_progression 
H-positive risk:  694 678 98 1141 376 87 1099 355 182 51 178 61 
H-negative risk:  678 694 1099 1141 355 376 87 98 178 182 61 51 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 104 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
132 
disease_progression 
H-positive risk:  686 685 98 1140 376 85 1100 356 185 49 184 56 
H-negative risk:  685 686 1100 1140 356 376 85 98 184 185 56 49 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 106 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
133 
disease_progression 
H-positive risk:  674 684 98 1144 370 88 1108 361 182 49 186 56 
H-negative risk:  684 674 1108 1144 361 370 88 98 186 182 56 49 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 108 23 

clinical_engagement 
diagnosis 
demography 
90 new agents 
134 
disease_progression 
H-positive risk:  668 682 100 1144 381 86 1105 364 182 51 181 56 
H-negative risk:  682 668 1105 1144 364 381 86 100 181 182 56 51 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 106 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
135 
disease_progression 
H-positive risk:  668 687 96 1137 389 87 1100 366 179 54 180 57 
H-negative risk:  687 668 1100 1137 366 389 87 96 180 179 57 54 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 103 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
136 
disease_progression 
H-positive risk:  664 681 94 1135 392 89 1107 364 182 55 178 59 
H-negative risk:  681 664 1107 1135 364 392 89 94 178 182 59 55 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 104 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
137 
disease_progression 
H-positive risk:  657 680 93 1139 393 89 1107 367 180 52 180 63 
H-negative risk:  680 657 1107 1139 367 393 89 93 180 180 63 52 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 101 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
138 
disease_progression 
H-positive risk:  651 681 95 1136 395 91 1109 366 179 53 179 65 
H-negative risk:  681 651 1109 1136 366 395 91 95 179 179 65 53 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 102 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
139 
disease_progression 
H-positive risk:  651 683 95 1149 381 92 1112 361 178 52 180 66 
H-negative risk:  683 651 1112 1149 361 381 92 95 180 178 66 52 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 100 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
140 
disease_progression 
H-positive risk:  648 680 96 1141 384 90 1122 368 179 51 175 66 
H-negative risk:  680 648 1122 1141 368 384 90 96 175 179 66 51 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 100 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
141 
disease_progression 
H-positive risk:  657 680 97 1140 384 92 1116 366 178 51 174 65 
H-negative risk:  680 657 1116 1140 366 384 92 97 174 178 65 51 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 100 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
142 
disease_progression 
H-positive risk:  657 679 95 1139 390 93 1107 372 176 50 176 66 
H-negative risk:  679 657 1107 1139 372 390 93 95 176 176 66 50 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 101 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
143 
disease_progression 
H-positive risk:  655 681 95 1139 391 93 1108 367 180 48 177 66 
H-negative risk:  681 655 1108 1139 367 391 93 95 177 180 66 48 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 104 22 

clinical_engagement 
diagnosis 
demography 
91 new agents 
144 
disease_progression 
H-positive risk:  665 681 95 1136 391 96 1106 364 178 46 179 63 
H-negative risk:  681 665 1106 1136 364 391 96 95 179 178 63 46 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 104 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
145 
disease_progression 
H-positive risk:  663 685 96 1129 388 95 1114 362 179 47 180 62 
H-negative risk:  685 663 1114 1129 362 388 95 96 180 179 62 47 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 106 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
146 
disease_progression 
H-positive risk:  667 688 94 1116 394 94 1116 361 173 52 180 65 
H-negative risk:  688 667 1116 1116 361 394 94 94 180 173 65 52 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 107 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
147 
disease_progression 
H-positive risk:  663 690 93 1110 403 93 1115 360 177 50 180 66 
H-negative risk:  690 663 1115 1110 360 403 93 93 180 177 66 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 101 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
148 
disease_progression 
H-positive risk:  662 688 95 1097 403 94 1124 367 174 51 180 65 
H-negative risk:  688 662 1124 1097 367 403 94 95 180 174 65 51 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 99 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
149 
disease_progression 
H-positive risk:  665 682 99 1095 405 95 1127 362 172 49 181 68 
H-negative risk:  682 665 1127 1095 362 405 95 99 181 172 68 49 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 103 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
150 
disease_progression 
H-positive risk:  660 682 102 1096 413 96 1129 362 168 49 178 65 
H-negative risk:  682 660 1129 1096 362 413 96 102 178 168 65 49 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 104 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
151 
disease_progression 
H-positive risk:  668 679 101 1101 407 96 1131 360 166 49 178 64 
H-negative risk:  679 668 1131 1101 360 407 96 101 178 166 64 49 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 109 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
152 
disease_progression 
H-positive risk:  665 676 99 1101 411 96 1134 358 168 51 177 64 
H-negative risk:  676 665 1134 1101 358 411 96 99 177 168 64 51 
New BC onsets:  135
BC status:  4865 135 
BC subtype:  4865 114 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
153 
disease_progression 
H-positive risk:  670 679 101 1105 403 98 1133 352 169 51 172 67 
H-negative risk:  679 670 1133 1105 352 403 98 101 172 169 67 51 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 113 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
154 
disease_progression 
H-positive risk:  673 681 101 1107 409 98 1122 352 171 49 171 66 
H-negative risk:  681 673 1122 1107 352 409 98 101 171 171 66 49 
New BC onsets:  136
BC status:  4864 136 
BC subtype:  4864 115 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
155 
disease_progression 
H-positive risk:  682 678 104 1114 400 98 1117 349 173 47 171 67 
H-negative risk:  678 682 1117 1114 349 400 98 104 171 173 67 47 
New BC onsets:  137
BC status:  4863 137 
BC subtype:  4863 116 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
156 
disease_progression 
H-positive risk:  670 679 104 1115 406 101 1125 350 171 44 170 65 
H-negative risk:  679 670 1125 1115 350 406 101 104 170 171 65 44 
New BC onsets:  135
BC status:  4865 135 
BC subtype:  4865 114 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
157 
disease_progression 
H-positive risk:  664 669 105 1124 409 102 1131 346 171 45 171 63 
H-negative risk:  669 664 1131 1124 346 409 102 105 171 171 63 45 
New BC onsets:  133
BC status:  4867 133 
BC subtype:  4867 114 19 

clinical_engagement 
diagnosis 
demography 
97 new agents 
158 
disease_progression 
H-positive risk:  658 676 98 1118 425 100 1128 352 169 43 171 62 
H-negative risk:  676 658 1128 1118 352 425 100 98 171 169 62 43 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 112 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
159 
disease_progression 
H-positive risk:  657 673 100 1107 435 104 1128 353 169 41 172 61 
H-negative risk:  673 657 1128 1107 353 435 104 100 172 169 61 41 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 110 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
160 
disease_progression 
H-positive risk:  656 670 103 1101 436 104 1126 361 173 40 170 60 
H-negative risk:  670 656 1126 1101 361 436 104 103 170 173 60 40 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 111 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
161 
disease_progression 
H-positive risk:  659 673 102 1104 441 104 1119 363 168 37 167 63 
H-negative risk:  673 659 1119 1104 363 441 104 102 167 168 63 37 
New BC onsets:  133
BC status:  4867 133 
BC subtype:  4867 112 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
162 
disease_progression 
H-positive risk:  660 670 101 1115 440 104 1120 361 166 35 162 66 
H-negative risk:  670 660 1120 1115 361 440 104 101 162 166 66 35 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 110 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
163 
disease_progression 
H-positive risk:  656 675 103 1107 436 110 1123 369 167 33 159 62 
H-negative risk:  675 656 1123 1107 369 436 110 103 159 167 62 33 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 109 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
164 
disease_progression 
H-positive risk:  660 677 98 1107 438 109 1129 362 168 32 160 60 
H-negative risk:  677 660 1129 1107 362 438 109 98 160 168 60 32 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 112 22 

clinical_engagement 
diagnosis 
demography 
93 new agents 
165 
disease_progression 
H-positive risk:  664 680 100 1111 430 107 1122 366 168 35 160 57 
H-negative risk:  680 664 1122 1111 366 430 107 100 160 168 57 35 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 110 22 

clinical_engagement 
diagnosis 
demography 
93 new agents 
166 
disease_progression 
H-positive risk:  664 685 99 1121 420 107 1124 361 168 36 161 54 
H-negative risk:  685 664 1124 1121 361 420 107 99 161 168 54 36 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 107 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
167 
disease_progression 
H-positive risk:  666 676 101 1121 427 107 1127 358 166 38 160 53 
H-negative risk:  676 666 1127 1121 358 427 107 101 160 166 53 38 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 108 22 

clinical_engagement 
diagnosis 
demography 
54 new agents 
168 
disease_progression 
H-positive risk:  664 678 103 1113 424 110 1124 363 167 39 161 54 
H-negative risk:  678 664 1124 1113 363 424 110 103 161 167 54 39 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 107 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
169 
disease_progression 
H-positive risk:  668 674 102 1121 418 114 1121 360 169 39 162 52 
H-negative risk:  674 668 1121 1121 360 418 114 102 162 169 52 39 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 105 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
170 
disease_progression 
H-positive risk:  661 672 104 1110 425 114 1115 377 171 40 159 52 
H-negative risk:  672 661 1115 1110 377 425 114 104 159 171 52 40 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 106 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
171 
disease_progression 
H-positive risk:  655 667 107 1114 426 117 1104 384 167 42 162 55 
H-negative risk:  667 655 1104 1114 384 426 117 107 162 167 55 42 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 106 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
172 
disease_progression 
H-positive risk:  655 667 107 1109 425 120 1100 397 163 43 158 56 
H-negative risk:  667 655 1100 1109 397 425 120 107 158 163 56 43 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 105 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
173 
disease_progression 
H-positive risk:  662 661 104 1110 428 122 1103 390 161 44 159 56 
H-negative risk:  661 662 1103 1110 390 428 122 104 159 161 56 44 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 103 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
174 
disease_progression 
H-positive risk:  663 652 103 1114 430 121 1102 392 162 43 163 55 
H-negative risk:  652 663 1102 1114 392 430 121 103 163 162 55 43 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 103 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
175 
disease_progression 
H-positive risk:  663 657 104 1107 432 119 1106 388 160 45 164 55 
H-negative risk:  657 663 1106 1107 388 432 119 104 164 160 55 45 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 104 24 

clinical_engagement 
diagnosis 
demography 
57 new agents 
176 
disease_progression 
H-positive risk:  664 657 104 1102 433 118 1112 390 157 45 163 55 
H-negative risk:  657 664 1112 1102 390 433 118 104 163 157 55 45 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 105 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
177 
disease_progression 
H-positive risk:  662 653 105 1110 426 116 1109 399 156 47 163 54 
H-negative risk:  653 662 1109 1110 399 426 116 105 163 156 54 47 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 105 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
178 
disease_progression 
H-positive risk:  655 658 105 1103 423 115 1116 406 155 47 164 53 
H-negative risk:  658 655 1116 1103 406 423 115 105 164 155 53 47 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 104 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
179 
disease_progression 
H-positive risk:  654 663 105 1105 414 114 1116 403 157 47 167 55 
H-negative risk:  663 654 1116 1105 403 414 114 105 167 157 55 47 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 104 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
180 
disease_progression 
H-positive risk:  654 659 105 1099 414 113 1128 409 159 47 162 51 
H-negative risk:  659 654 1128 1099 409 414 113 105 162 159 51 47 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 104 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
181 
disease_progression 
H-positive risk:  654 666 104 1099 414 112 1123 407 160 49 159 53 
H-negative risk:  666 654 1123 1099 407 414 112 104 159 160 53 49 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 105 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
182 
disease_progression 
H-positive risk:  644 665 100 1099 408 113 1131 414 158 50 157 61 
H-negative risk:  665 644 1131 1099 414 408 113 100 157 158 61 50 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 103 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
183 
disease_progression 
H-positive risk:  645 670 102 1091 411 114 1120 423 158 51 155 60 
H-negative risk:  670 645 1120 1091 423 411 114 102 155 158 60 51 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 103 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
184 
disease_progression 
H-positive risk:  647 671 107 1091 410 115 1119 417 158 50 157 58 
H-negative risk:  671 647 1119 1091 417 410 115 107 157 158 58 50 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 101 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
185 
disease_progression 
H-positive risk:  649 673 109 1083 408 115 1119 422 155 49 162 56 
H-negative risk:  673 649 1119 1083 422 408 115 109 162 155 56 49 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 108 26 

clinical_engagement 
diagnosis 
demography 
91 new agents 
186 
disease_progression 
H-positive risk:  650 671 108 1085 408 116 1128 415 153 47 160 59 
H-negative risk:  671 650 1128 1085 415 408 116 108 160 153 59 47 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 106 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
187 
disease_progression 
H-positive risk:  637 661 112 1097 411 114 1137 412 156 47 159 57 
H-negative risk:  661 637 1137 1097 412 411 114 112 159 156 57 47 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 103 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
188 
disease_progression 
H-positive risk:  627 648 112 1107 409 113 1147 413 158 48 162 56 
H-negative risk:  648 627 1147 1107 413 409 113 112 162 158 56 48 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 100 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
189 
disease_progression 
H-positive risk:  624 646 109 1112 413 113 1145 413 161 46 163 55 
H-negative risk:  646 624 1145 1112 413 413 113 109 163 161 55 46 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 98 24 

clinical_engagement 
diagnosis 
demography 
50 new agents 
190 
disease_progression 
H-positive risk:  623 646 108 1113 412 112 1143 409 164 48 166 56 
H-negative risk:  646 623 1143 1113 409 412 112 108 166 164 56 48 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 99 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
191 
disease_progression 
H-positive risk:  625 640 106 1114 417 113 1133 410 162 53 169 58 
H-negative risk:  640 625 1133 1114 410 417 113 106 169 162 58 53 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 101 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
192 
disease_progression 
H-positive risk:  628 648 107 1113 410 111 1130 410 163 53 166 61 
H-negative risk:  648 628 1130 1113 410 410 111 107 166 163 61 53 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 101 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
193 
disease_progression 
H-positive risk:  622 645 110 1115 413 110 1136 404 169 51 164 61 
H-negative risk:  645 622 1136 1115 404 413 110 110 164 169 61 51 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 101 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
194 
disease_progression 
H-positive risk:  625 639 112 1108 428 109 1120 410 171 51 162 65 
H-negative risk:  639 625 1120 1108 410 428 109 112 162 171 65 51 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
102 new agents 
195 
disease_progression 
H-positive risk:  629 644 114 1119 410 110 1119 406 176 49 161 63 
H-negative risk:  644 629 1119 1119 406 410 110 114 161 176 63 49 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 95 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
196 
disease_progression 
H-positive risk:  638 646 115 1120 400 109 1124 398 179 49 159 63 
H-negative risk:  646 638 1124 1120 398 400 109 115 159 179 63 49 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
197 
disease_progression 
H-positive risk:  636 642 115 1114 417 107 1119 398 182 52 159 59 
H-negative risk:  642 636 1119 1114 398 417 107 115 159 182 59 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
198 
disease_progression 
H-positive risk:  645 641 116 1122 416 108 1104 403 182 53 156 54 
H-negative risk:  641 645 1104 1122 403 416 108 116 156 182 54 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
199 
disease_progression 
H-positive risk:  639 647 116 1123 414 106 1101 399 189 53 154 59 
H-negative risk:  647 639 1101 1123 399 414 106 116 154 189 59 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
200 
disease_progression 
H-positive risk:  635 650 115 1110 411 105 1112 401 193 52 158 58 
H-negative risk:  650 635 1112 1110 401 411 105 115 158 193 58 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
201 
disease_progression 
H-positive risk:  631 649 115 1109 413 104 1111 406 188 57 158 59 
H-negative risk:  649 631 1111 1109 406 413 104 115 158 188 59 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
202 
disease_progression 
H-positive risk:  637 643 112 1107 413 104 1111 413 185 58 159 58 
H-negative risk:  643 637 1111 1107 413 413 104 112 159 185 58 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
203 
disease_progression 
H-positive risk:  634 647 115 1107 413 103 1109 411 185 61 158 57 
H-negative risk:  647 634 1109 1107 411 413 103 115 158 185 57 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
204 
disease_progression 
H-positive risk:  628 640 116 1123 404 100 1109 415 187 60 160 58 
H-negative risk:  640 628 1109 1123 415 404 100 116 160 187 58 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
205 
disease_progression 
H-positive risk:  632 633 116 1130 400 102 1112 412 186 60 159 58 
H-negative risk:  633 632 1112 1130 412 400 102 116 159 186 58 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
94 new agents 
206 
disease_progression 
H-positive risk:  630 640 114 1124 404 101 1112 412 182 60 161 60 
H-negative risk:  640 630 1112 1124 412 404 101 114 161 182 60 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
207 
disease_progression 
H-positive risk:  634 634 112 1125 404 103 1111 415 181 60 160 61 
H-negative risk:  634 634 1111 1125 415 404 103 112 160 181 61 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
208 
disease_progression 
H-positive risk:  639 634 111 1128 400 102 1106 424 178 61 158 59 
H-negative risk:  634 639 1106 1128 424 400 102 111 158 178 59 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
209 
disease_progression 
H-positive risk:  634 624 114 1131 405 101 1105 425 179 62 162 58 
H-negative risk:  624 634 1105 1131 425 405 101 114 162 179 58 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
210 
disease_progression 
H-positive risk:  635 617 112 1137 399 102 1123 420 175 60 161 59 
H-negative risk:  617 635 1123 1137 420 399 102 112 161 175 59 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
211 
disease_progression 
H-positive risk:  631 629 112 1130 413 104 1109 423 176 58 160 55 
H-negative risk:  629 631 1109 1130 423 413 104 112 160 176 55 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
212 
disease_progression 
H-positive risk:  625 632 114 1143 408 103 1105 420 177 58 161 54 
H-negative risk:  632 625 1105 1143 420 408 103 114 161 177 54 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
213 
disease_progression 
H-positive risk:  626 634 112 1149 404 103 1104 419 174 57 161 57 
H-negative risk:  634 626 1104 1149 419 404 103 112 161 174 57 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
214 
disease_progression 
H-positive risk:  635 634 113 1147 401 104 1097 422 171 59 160 57 
H-negative risk:  634 635 1097 1147 422 401 104 113 160 171 57 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
215 
disease_progression 
H-positive risk:  638 632 113 1157 400 104 1094 421 165 57 159 60 
H-negative risk:  632 638 1094 1157 421 400 104 113 159 165 60 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
216 
disease_progression 
H-positive risk:  647 627 113 1169 401 104 1085 416 164 53 159 62 
H-negative risk:  627 647 1085 1169 416 401 104 113 159 164 62 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
217 
disease_progression 
H-positive risk:  655 629 112 1164 403 102 1073 416 161 58 162 65 
H-negative risk:  629 655 1073 1164 416 403 102 112 162 161 65 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
218 
disease_progression 
H-positive risk:  655 634 109 1166 391 104 1081 408 163 60 166 63 
H-negative risk:  634 655 1081 1166 408 391 104 109 166 163 63 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
219 
disease_progression 
H-positive risk:  662 631 109 1167 388 106 1074 413 161 61 166 62 
H-negative risk:  631 662 1074 1167 413 388 106 109 166 161 62 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
92 new agents 
220 
disease_progression 
H-positive risk:  661 630 108 1151 403 111 1073 414 161 61 167 60 
H-negative risk:  630 661 1073 1151 414 403 111 108 167 161 60 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
221 
disease_progression 
H-positive risk:  665 635 105 1149 404 114 1064 416 161 60 169 58 
H-negative risk:  635 665 1064 1149 416 404 114 105 169 161 58 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
222 
disease_progression 
H-positive risk:  662 633 108 1150 408 115 1063 416 163 58 167 57 
H-negative risk:  633 662 1063 1150 416 408 115 108 167 163 57 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
223 
disease_progression 
H-positive risk:  662 632 106 1160 402 111 1066 415 168 56 166 56 
H-negative risk:  632 662 1066 1160 415 402 111 106 166 168 56 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
224 
disease_progression 
H-positive risk:  660 642 105 1151 406 112 1063 418 170 56 163 54 
H-negative risk:  642 660 1063 1151 418 406 112 105 163 170 54 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
225 
disease_progression 
H-positive risk:  652 635 108 1153 417 111 1057 423 166 58 166 54 
H-negative risk:  635 652 1057 1153 423 417 111 108 166 166 54 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
226 
disease_progression 
H-positive risk:  649 633 108 1154 419 110 1055 419 168 59 171 55 
H-negative risk:  633 649 1055 1154 419 419 110 108 171 168 55 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
227 
disease_progression 
H-positive risk:  646 634 107 1156 417 109 1059 420 167 58 170 57 
H-negative risk:  634 646 1059 1156 420 417 109 107 170 167 57 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
228 
disease_progression 
H-positive risk:  650 639 104 1151 418 109 1052 421 166 58 173 59 
H-negative risk:  639 650 1052 1151 421 418 109 104 173 166 59 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
229 
disease_progression 
H-positive risk:  648 634 105 1150 436 107 1039 427 164 59 169 62 
H-negative risk:  634 648 1039 1150 427 436 107 105 169 164 62 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
230 
disease_progression 
H-positive risk:  649 631 104 1156 435 108 1035 431 166 56 167 62 
H-negative risk:  631 649 1035 1156 431 435 108 104 167 166 62 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
231 
disease_progression 
H-positive risk:  653 633 102 1159 437 109 1025 429 164 56 170 63 
H-negative risk:  633 653 1025 1159 429 437 109 102 170 164 63 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
232 
disease_progression 
H-positive risk:  651 635 100 1162 429 109 1025 427 166 57 177 62 
H-negative risk:  635 651 1025 1162 427 429 109 100 177 166 62 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
233 
disease_progression 
H-positive risk:  659 643 100 1152 433 108 1024 418 168 58 175 62 
H-negative risk:  643 659 1024 1152 418 433 108 100 175 168 62 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
234 
disease_progression 
H-positive risk:  663 651 100 1140 434 108 1022 418 170 58 171 65 
H-negative risk:  651 663 1022 1140 418 434 108 100 171 170 65 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
235 
disease_progression 
H-positive risk:  656 647 101 1145 434 108 1022 421 170 60 171 65 
H-negative risk:  647 656 1022 1145 421 434 108 101 171 170 65 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
236 
disease_progression 
H-positive risk:  661 644 101 1140 430 104 1027 427 169 61 170 66 
H-negative risk:  644 661 1027 1140 427 430 104 101 170 169 66 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
237 
disease_progression 
H-positive risk:  661 639 101 1134 436 102 1032 430 168 62 169 66 
H-negative risk:  639 661 1032 1134 430 436 102 101 169 168 66 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
238 
disease_progression 
H-positive risk:  647 643 103 1144 434 101 1038 429 169 61 165 66 
H-negative risk:  643 647 1038 1144 429 434 101 103 165 169 66 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
239 
disease_progression 
H-positive risk:  653 651 104 1138 436 99 1033 428 167 62 163 66 
H-negative risk:  651 653 1033 1138 428 436 99 104 163 167 66 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
240 
disease_progression 
H-positive risk:  657 653 105 1130 433 100 1036 431 166 61 162 66 
H-negative risk:  653 657 1036 1130 431 433 100 105 162 166 66 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
241 
disease_progression 
H-positive risk:  659 651 107 1129 438 101 1024 447 163 58 156 67 
H-negative risk:  651 659 1024 1129 447 438 101 107 156 163 67 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
242 
disease_progression 
H-positive risk:  657 652 107 1138 434 97 1030 444 164 56 155 66 
H-negative risk:  652 657 1030 1138 444 434 97 107 155 164 66 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
243 
disease_progression 
H-positive risk:  660 652 108 1142 434 97 1026 438 164 56 159 64 
H-negative risk:  652 660 1026 1142 438 434 97 108 159 164 64 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
244 
disease_progression 
H-positive risk:  652 652 110 1138 440 100 1034 438 160 57 158 61 
H-negative risk:  652 652 1034 1138 438 440 100 110 158 160 61 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
245 
disease_progression 
H-positive risk:  653 658 112 1133 429 101 1037 441 158 57 160 61 
H-negative risk:  658 653 1037 1133 441 429 101 112 160 158 61 57 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
246 
disease_progression 
H-positive risk:  651 668 111 1128 429 101 1052 430 157 57 157 59 
H-negative risk:  668 651 1052 1128 430 429 101 111 157 157 59 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
247 
disease_progression 
H-positive risk:  652 664 107 1128 433 100 1051 432 154 60 158 61 
H-negative risk:  664 652 1051 1128 432 433 100 107 158 154 61 60 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
248 
disease_progression 
H-positive risk:  653 671 109 1121 432 100 1057 428 154 59 157 59 
H-negative risk:  671 653 1057 1121 428 432 100 109 157 154 59 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
249 
disease_progression 
H-positive risk:  652 671 107 1122 433 101 1056 427 152 60 160 59 
H-negative risk:  671 652 1056 1122 427 433 101 107 160 152 59 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
250 
disease_progression 
H-positive risk:  657 676 104 1122 431 103 1053 427 149 59 161 58 
H-negative risk:  676 657 1053 1122 427 431 103 104 161 149 58 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
251 
disease_progression 
H-positive risk:  653 677 104 1124 427 103 1053 428 153 58 159 61 
H-negative risk:  677 653 1053 1124 428 427 103 104 159 153 61 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
86 new agents 
252 
disease_progression 
H-positive risk:  656 678 104 1125 436 104 1057 415 151 54 158 62 
H-negative risk:  678 656 1057 1125 415 436 104 104 158 151 62 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
91 new agents 
253 
disease_progression 
H-positive risk:  666 678 100 1131 430 108 1059 406 149 54 158 61 
H-negative risk:  678 666 1059 1131 406 430 108 100 158 149 61 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
254 
disease_progression 
H-positive risk:  666 678 100 1130 427 108 1062 396 152 57 162 62 
H-negative risk:  678 666 1062 1130 396 427 108 100 162 152 62 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
255 
disease_progression 
H-positive risk:  663 674 99 1127 431 106 1071 398 146 59 162 64 
H-negative risk:  674 663 1071 1127 398 431 106 99 162 146 64 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
256 
disease_progression 
H-positive risk:  660 678 100 1115 436 106 1077 395 148 58 165 62 
H-negative risk:  678 660 1077 1115 395 436 106 100 165 148 62 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
257 
disease_progression 
H-positive risk:  658 685 100 1114 434 106 1079 398 142 60 161 63 
H-negative risk:  685 658 1079 1114 398 434 106 100 161 142 63 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
258 
disease_progression 
H-positive risk:  647 686 100 1115 433 107 1084 402 144 59 158 65 
H-negative risk:  686 647 1084 1115 402 433 107 100 158 144 65 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
259 
disease_progression 
H-positive risk:  651 689 98 1106 441 105 1081 401 145 59 163 61 
H-negative risk:  689 651 1081 1106 401 441 105 98 163 145 61 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
260 
disease_progression 
H-positive risk:  664 694 97 1102 444 104 1065 402 145 60 164 59 
H-negative risk:  694 664 1065 1102 402 444 104 97 164 145 59 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
261 
disease_progression 
H-positive risk:  659 700 97 1108 434 104 1068 407 146 60 161 56 
H-negative risk:  700 659 1068 1108 407 434 104 97 161 146 56 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
262 
disease_progression 
H-positive risk:  656 699 94 1108 436 105 1074 402 147 60 159 60 
H-negative risk:  699 656 1074 1108 402 436 105 94 159 147 60 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
263 
disease_progression 
H-positive risk:  654 700 93 1109 439 106 1068 403 149 58 161 60 
H-negative risk:  700 654 1068 1109 403 439 106 93 161 149 60 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
264 
disease_progression 
H-positive risk:  642 696 95 1110 438 107 1074 406 151 58 163 60 
H-negative risk:  696 642 1074 1110 406 438 107 95 163 151 60 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
265 
disease_progression 
H-positive risk:  637 698 96 1109 440 106 1070 412 155 56 162 59 
H-negative risk:  698 637 1070 1109 412 440 106 96 162 155 59 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
102 new agents 
266 
disease_progression 
H-positive risk:  642 707 96 1106 440 105 1058 409 157 54 164 62 
H-negative risk:  707 642 1058 1106 409 440 105 96 164 157 62 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
267 
disease_progression 
H-positive risk:  650 699 95 1097 434 103 1064 419 155 55 167 62 
H-negative risk:  699 650 1064 1097 419 434 103 95 167 155 62 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
268 
disease_progression 
H-positive risk:  644 694 94 1095 440 101 1067 428 152 57 166 62 
H-negative risk:  694 644 1067 1095 428 440 101 94 166 152 62 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
269 
disease_progression 
H-positive risk:  648 704 94 1084 439 101 1065 422 156 55 166 66 
H-negative risk:  704 648 1065 1084 422 439 101 94 166 156 66 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
270 
disease_progression 
H-positive risk:  657 702 95 1091 440 99 1047 424 158 54 168 65 
H-negative risk:  702 657 1047 1091 424 440 99 95 168 158 65 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
271 
disease_progression 
H-positive risk:  671 703 96 1098 427 97 1038 421 160 56 168 65 
H-negative risk:  703 671 1038 1098 421 427 97 96 168 160 65 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
272 
disease_progression 
H-positive risk:  673 698 99 1110 420 98 1035 421 157 52 173 64 
H-negative risk:  698 673 1035 1110 421 420 98 99 173 157 64 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
273 
disease_progression 
H-positive risk:  679 699 98 1105 425 100 1034 420 155 51 174 60 
H-negative risk:  699 679 1034 1105 420 425 100 98 174 155 60 51 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
93 new agents 
274 
disease_progression 
H-positive risk:  674 706 101 1108 424 101 1033 420 154 51 171 57 
H-negative risk:  706 674 1033 1108 420 424 101 101 171 154 57 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
275 
disease_progression 
H-positive risk:  668 706 103 1114 421 104 1027 424 156 50 170 57 
H-negative risk:  706 668 1027 1114 424 421 104 103 170 156 57 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
276 
disease_progression 
H-positive risk:  680 711 102 1112 416 103 1025 416 156 49 173 57 
H-negative risk:  711 680 1025 1112 416 416 103 102 173 156 57 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
98 new agents 
277 
disease_progression 
H-positive risk:  685 718 105 1110 409 100 1028 416 151 47 172 59 
H-negative risk:  718 685 1028 1110 416 409 100 105 172 151 59 47 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
66 new agents 
278 
disease_progression 
H-positive risk:  679 717 104 1109 411 101 1031 421 150 45 173 59 
H-negative risk:  717 679 1031 1109 421 411 101 104 173 150 59 45 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
279 
disease_progression 
H-positive risk:  670 720 104 1094 421 100 1041 424 150 45 174 57 
H-negative risk:  720 670 1041 1094 424 421 100 104 174 150 57 45 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
280 
disease_progression 
H-positive risk:  674 722 104 1095 418 97 1037 421 153 45 174 60 
H-negative risk:  722 674 1037 1095 421 418 97 104 174 153 60 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
281 
disease_progression 
H-positive risk:  681 717 100 1094 416 97 1036 418 156 44 176 65 
H-negative risk:  717 681 1036 1094 418 416 97 100 176 156 65 44 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
282 
disease_progression 
H-positive risk:  680 711 99 1109 404 96 1037 421 156 47 173 67 
H-negative risk:  711 680 1037 1109 421 404 96 99 173 156 67 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
283 
disease_progression 
H-positive risk:  682 710 98 1114 412 93 1030 418 152 46 176 69 
H-negative risk:  710 682 1030 1114 418 412 93 98 176 152 69 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
284 
disease_progression 
H-positive risk:  686 708 97 1118 408 93 1029 412 151 50 177 71 
H-negative risk:  708 686 1029 1118 412 408 93 97 177 151 71 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
285 
disease_progression 
H-positive risk:  682 706 97 1117 412 94 1032 410 152 48 179 71 
H-negative risk:  706 682 1032 1117 410 412 94 97 179 152 71 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
286 
disease_progression 
H-positive risk:  684 702 95 1132 400 95 1027 418 149 48 178 72 
H-negative risk:  702 684 1027 1132 418 400 95 95 178 149 72 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
287 
disease_progression 
H-positive risk:  679 702 93 1126 403 94 1037 422 148 50 176 70 
H-negative risk:  702 679 1037 1126 422 403 94 93 176 148 70 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
288 
disease_progression 
H-positive risk:  683 713 91 1123 405 90 1041 411 148 49 179 67 
H-negative risk:  713 683 1041 1123 411 405 90 91 179 148 67 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
289 
disease_progression 
H-positive risk:  683 711 93 1118 405 91 1050 409 146 49 178 67 
H-negative risk:  711 683 1050 1118 409 405 91 93 178 146 67 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
97 new agents 
290 
disease_progression 
H-positive risk:  686 710 92 1109 402 90 1062 406 148 49 178 68 
H-negative risk:  710 686 1062 1109 406 402 90 92 178 148 68 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
291 
disease_progression 
H-positive risk:  685 704 92 1110 405 91 1061 402 153 50 178 69 
H-negative risk:  704 685 1061 1110 402 405 91 92 178 153 69 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
292 
disease_progression 
H-positive risk:  686 699 93 1108 407 95 1056 407 153 51 176 69 
H-negative risk:  699 686 1056 1108 407 407 95 93 176 153 69 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
293 
disease_progression 
H-positive risk:  688 708 95 1097 410 97 1053 405 151 52 169 75 
H-negative risk:  708 688 1053 1097 405 410 97 95 169 151 75 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
294 
disease_progression 
H-positive risk:  684 710 94 1112 398 95 1055 401 155 52 169 75 
H-negative risk:  710 684 1055 1112 401 398 95 94 169 155 75 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
295 
disease_progression 
H-positive risk:  686 713 95 1115 395 93 1053 404 154 50 169 73 
H-negative risk:  713 686 1053 1115 404 395 93 95 169 154 73 50 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
296 
disease_progression 
H-positive risk:  688 709 96 1128 394 93 1054 400 152 48 167 71 
H-negative risk:  709 688 1054 1128 400 394 93 96 167 152 71 48 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
297 
disease_progression 
H-positive risk:  690 700 98 1133 395 95 1052 397 152 50 168 70 
H-negative risk:  700 690 1052 1133 397 395 95 98 168 152 70 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
298 
disease_progression 
H-positive risk:  687 706 100 1126 402 94 1053 390 149 51 169 73 
H-negative risk:  706 687 1053 1126 390 402 94 100 169 149 73 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
299 
disease_progression 
H-positive risk:  682 707 99 1134 397 96 1057 385 150 50 171 72 
H-negative risk:  707 682 1057 1134 385 397 96 99 171 150 72 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
300 
disease_progression 
H-positive risk:  677 710 97 1128 399 95 1062 391 150 49 168 74 
H-negative risk:  710 677 1062 1128 391 399 95 97 168 150 74 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
301 
disease_progression 
H-positive risk:  684 716 98 1121 399 93 1063 389 148 50 163 76 
H-negative risk:  716 684 1063 1121 389 399 93 98 163 148 76 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
302 
disease_progression 
H-positive risk:  677 718 100 1119 402 93 1059 393 155 47 162 75 
H-negative risk:  718 677 1059 1119 393 402 93 100 162 155 75 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
303 
disease_progression 
H-positive risk:  674 722 98 1121 402 93 1060 392 155 48 160 75 
H-negative risk:  722 674 1060 1121 392 402 93 98 160 155 75 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
304 
disease_progression 
H-positive risk:  676 719 98 1121 404 97 1060 384 153 53 161 74 
H-negative risk:  719 676 1060 1121 384 404 97 98 161 153 74 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
305 
disease_progression 
H-positive risk:  675 718 99 1117 404 96 1069 383 150 52 163 74 
H-negative risk:  718 675 1069 1117 383 404 96 99 163 150 74 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
306 
disease_progression 
H-positive risk:  666 715 101 1123 403 98 1075 384 151 54 158 72 
H-negative risk:  715 666 1075 1123 384 403 98 101 158 151 72 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
307 
disease_progression 
H-positive risk:  668 720 104 1123 401 98 1069 386 151 55 158 67 
H-negative risk:  720 668 1069 1123 386 401 98 104 158 151 67 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
308 
disease_progression 
H-positive risk:  670 725 101 1120 401 100 1077 379 149 56 154 68 
H-negative risk:  725 670 1077 1120 379 401 100 101 154 149 68 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
309 
disease_progression 
H-positive risk:  677 731 101 1112 403 99 1085 371 143 59 152 67 
H-negative risk:  731 677 1085 1112 371 403 99 101 152 143 67 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
310 
disease_progression 
H-positive risk:  683 730 100 1114 400 99 1071 374 147 60 158 64 
H-negative risk:  730 683 1071 1114 374 400 99 100 158 147 64 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
311 
disease_progression 
H-positive risk:  685 720 97 1114 405 101 1077 365 150 61 162 63 
H-negative risk:  720 685 1077 1114 365 405 101 97 162 150 63 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
312 
disease_progression 
H-positive risk:  681 720 102 1120 395 102 1079 368 147 62 162 62 
H-negative risk:  720 681 1079 1120 368 395 102 102 162 147 62 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
313 
disease_progression 
H-positive risk:  674 724 100 1121 396 101 1092 363 144 62 161 62 
H-negative risk:  724 674 1092 1121 363 396 101 100 161 144 62 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
314 
disease_progression 
H-positive risk:  665 717 100 1117 404 98 1093 371 148 61 164 62 
H-negative risk:  717 665 1093 1117 371 404 98 100 164 148 62 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
315 
disease_progression 
H-positive risk:  657 715 99 1118 415 95 1090 371 153 60 167 60 
H-negative risk:  715 657 1090 1118 371 415 95 99 167 153 60 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
316 
disease_progression 
H-positive risk:  664 714 99 1112 416 94 1093 368 156 60 164 60 
H-negative risk:  714 664 1093 1112 368 416 94 99 164 156 60 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
317 
disease_progression 
H-positive risk:  664 707 98 1117 419 94 1097 367 154 60 164 59 
H-negative risk:  707 664 1097 1117 367 419 94 98 164 154 59 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
318 
disease_progression 
H-positive risk:  666 706 96 1114 431 93 1087 374 154 60 164 55 
H-negative risk:  706 666 1087 1114 374 431 93 96 164 154 55 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
319 
disease_progression 
H-positive risk:  665 706 93 1112 433 96 1086 377 153 61 163 55 
H-negative risk:  706 665 1086 1112 377 433 96 93 163 153 55 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
320 
disease_progression 
H-positive risk:  662 711 95 1101 435 96 1089 380 154 59 162 56 
H-negative risk:  711 662 1089 1101 380 435 96 95 162 154 56 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
61 new agents 
321 
disease_progression 
H-positive risk:  657 706 93 1107 438 96 1087 381 155 60 164 56 
H-negative risk:  706 657 1087 1107 381 438 96 93 164 155 56 60 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
322 
disease_progression 
H-positive risk:  655 706 95 1111 433 96 1084 384 154 62 166 54 
H-negative risk:  706 655 1084 1111 384 433 96 95 166 154 54 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
323 
disease_progression 
H-positive risk:  654 695 98 1111 439 96 1088 382 157 61 167 52 
H-negative risk:  695 654 1088 1111 382 439 96 98 167 157 52 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
324 
disease_progression 
H-positive risk:  655 697 97 1118 432 95 1078 386 158 60 166 58 
H-negative risk:  697 655 1078 1118 386 432 95 97 166 158 58 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
325 
disease_progression 
H-positive risk:  657 697 100 1121 438 93 1070 387 156 61 163 57 
H-negative risk:  697 657 1070 1121 387 438 93 100 163 156 57 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
326 
disease_progression 
H-positive risk:  663 702 100 1112 440 90 1065 394 157 59 160 58 
H-negative risk:  702 663 1065 1112 394 440 90 100 160 157 58 59 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
327 
disease_progression 
H-positive risk:  658 700 101 1103 442 89 1077 398 159 57 161 55 
H-negative risk:  700 658 1077 1103 398 442 89 101 161 159 55 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
328 
disease_progression 
H-positive risk:  653 694 102 1102 448 90 1081 398 161 56 158 57 
H-negative risk:  694 653 1081 1102 398 448 90 102 158 161 57 56 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
329 
disease_progression 
H-positive risk:  654 690 105 1106 446 88 1077 399 161 57 159 58 
H-negative risk:  690 654 1077 1106 399 446 88 105 159 161 58 57 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 65 23 

clinical_engagement 
diagnosis 
demography 
90 new agents 
330 
disease_progression 
H-positive risk:  657 681 105 1109 448 89 1076 392 162 58 162 61 
H-negative risk:  681 657 1076 1109 392 448 89 105 162 162 61 58 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
331 
disease_progression 
H-positive risk:  658 681 105 1111 444 88 1080 389 162 58 162 62 
H-negative risk:  681 658 1080 1111 389 444 88 105 162 162 62 58 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
55 new agents 
332 
disease_progression 
H-positive risk:  657 672 105 1112 449 89 1082 387 161 60 162 64 
H-negative risk:  672 657 1082 1112 387 449 89 105 162 161 64 60 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
333 
disease_progression 
H-positive risk:  648 682 105 1097 449 92 1083 391 164 61 160 68 
H-negative risk:  682 648 1083 1097 391 449 92 105 160 164 68 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
334 
disease_progression 
H-positive risk:  650 675 108 1095 449 90 1084 393 169 60 159 68 
H-negative risk:  675 650 1084 1095 393 449 90 108 159 169 68 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
335 
disease_progression 
H-positive risk:  658 669 110 1104 454 88 1080 388 169 57 156 67 
H-negative risk:  669 658 1080 1104 388 454 88 110 156 169 67 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
336 
disease_progression 
H-positive risk:  667 665 108 1096 459 87 1080 383 171 59 157 68 
H-negative risk:  665 667 1080 1096 383 459 87 108 157 171 68 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
337 
disease_progression 
H-positive risk:  668 662 105 1108 458 89 1078 381 170 55 157 69 
H-negative risk:  662 668 1078 1108 381 458 89 105 157 170 69 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
338 
disease_progression 
H-positive risk:  676 663 106 1103 457 88 1069 390 170 51 158 69 
H-negative risk:  663 676 1069 1103 390 457 88 106 158 170 69 51 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
58 new agents 
339 
disease_progression 
H-positive risk:  681 662 106 1090 467 88 1069 391 171 51 154 70 
H-negative risk:  662 681 1069 1090 391 467 88 106 154 171 70 51 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
340 
disease_progression 
H-positive risk:  681 663 108 1086 465 86 1073 392 171 52 154 69 
H-negative risk:  663 681 1073 1086 392 465 86 108 154 171 69 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
60 new agents 
341 
disease_progression 
H-positive risk:  682 658 102 1090 463 87 1076 396 167 54 158 67 
H-negative risk:  658 682 1076 1090 396 463 87 102 158 167 67 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
342 
disease_progression 
H-positive risk:  680 652 104 1092 464 86 1081 399 167 53 157 65 
H-negative risk:  652 680 1081 1092 399 464 86 104 157 167 65 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
343 
disease_progression 
H-positive risk:  676 658 105 1083 464 84 1082 395 171 56 159 67 
H-negative risk:  658 676 1082 1083 395 464 84 105 159 171 67 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 69 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
344 
disease_progression 
H-positive risk:  677 653 108 1079 459 84 1087 399 173 55 159 67 
H-negative risk:  653 677 1087 1079 399 459 84 108 159 173 67 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 70 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
345 
disease_progression 
H-positive risk:  681 652 103 1081 458 84 1078 411 174 50 161 67 
H-negative risk:  652 681 1078 1081 411 458 84 103 161 174 67 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
346 
disease_progression 
H-positive risk:  684 652 102 1088 453 84 1073 410 174 50 164 66 
H-negative risk:  652 684 1073 1088 410 453 84 102 164 174 66 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
347 
disease_progression 
H-positive risk:  681 652 102 1085 457 85 1072 410 175 51 164 66 
H-negative risk:  652 681 1072 1085 410 457 85 102 164 175 66 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
348 
disease_progression 
H-positive risk:  677 649 98 1095 456 84 1082 403 172 53 167 64 
H-negative risk:  649 677 1082 1095 403 456 84 98 167 172 64 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
70 new agents 
349 
disease_progression 
H-positive risk:  668 651 99 1094 456 82 1089 400 173 55 168 65 
H-negative risk:  651 668 1089 1094 400 456 82 99 168 173 65 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
350 
disease_progression 
H-positive risk:  676 648 100 1095 452 79 1088 401 176 54 165 66 
H-negative risk:  648 676 1088 1095 401 452 79 100 165 176 66 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 70 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
351 
disease_progression 
H-positive risk:  680 647 98 1090 448 83 1086 407 172 57 168 64 
H-negative risk:  647 680 1086 1090 407 448 83 98 168 172 64 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 70 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
352 
disease_progression 
H-positive risk:  681 650 99 1086 452 78 1085 400 176 61 164 68 
H-negative risk:  650 681 1085 1086 400 452 78 99 164 176 68 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
353 
disease_progression 
H-positive risk:  675 650 101 1080 454 78 1091 399 176 63 163 70 
H-negative risk:  650 675 1091 1080 399 454 78 101 163 176 70 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
354 
disease_progression 
H-positive risk:  671 648 102 1079 447 77 1102 397 175 67 163 72 
H-negative risk:  648 671 1102 1079 397 447 77 102 163 175 72 67 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 70 29 

clinical_engagement 
diagnosis 
demography 
97 new agents 
355 
disease_progression 
H-positive risk:  671 650 105 1078 445 75 1105 393 179 66 163 70 
H-negative risk:  650 671 1105 1078 393 445 75 105 163 179 70 66 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
356 
disease_progression 
H-positive risk:  679 649 106 1079 445 75 1099 390 181 64 164 69 
H-negative risk:  649 679 1099 1079 390 445 75 106 164 181 69 64 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
357 
disease_progression 
H-positive risk:  686 647 103 1076 446 73 1090 396 180 67 165 71 
H-negative risk:  647 686 1090 1076 396 446 73 103 165 180 71 67 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
102 new agents 
358 
disease_progression 
H-positive risk:  697 653 103 1077 430 71 1087 396 182 68 166 70 
H-negative risk:  653 697 1087 1077 396 430 71 103 166 182 70 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
359 
disease_progression 
H-positive risk:  696 650 101 1066 432 69 1106 391 183 68 167 71 
H-negative risk:  650 696 1106 1066 391 432 69 101 167 183 71 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
360 
disease_progression 
H-positive risk:  690 652 100 1060 439 70 1111 385 181 70 173 69 
H-negative risk:  652 690 1111 1060 385 439 70 100 173 181 69 70 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
Time difference of 18.80218 mins
This is task 7
date
